💊 Striving to Improve the Efficacy of Obesity, Diabetes Treatments | Syracuse University Today
Автор: Syracuse University Today
Загружено: 2025-09-30
Просмотров: 13
What if you could lose weight and control diabetes without the debilitating side effects? Syracuse University medicinal chemist Robert Doyle may have just cracked the code. As the Jack and Laura H. Milton Professor and Dean's Professor of Chemistry, Doyle has developed groundbreaking peptide-based treatments—GEP44 and KCEM1—that are revolutionizing how we approach obesity and type 2 diabetes.
Unlike current GLP-1 drugs that often leave patients suffering from nausea and other harsh side effects, Doyle's compounds deliver significant weight loss and blood glucose control without the misery. On this "'Cuse Conversation," discover the cutting-edge science behind this pharmaceutical breakthrough, learn how student researchers are driving innovation in the lab and find out how philanthropic support is transforming laboratory discoveries into life-changing treatments.
#SyracuseU #Research #Faculty #HigherEducation #Podcast #Obesity #Diabetes #Chemistry #WeightLoss #DiabetesResearch #MedicinalChemistry
This podcast was originally published on March 25, 2025.
--------------
For more news and content:
https://www.news.syr.edu
/ syracuseutoday
https://www.x.com/SyracuseUToday
/ syracuse-university-today
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
